View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 25, 2022

Abilitech Medical secures Health Canada licence to sell orthotic device

Last year, Abilitech and the Praxis Spinal Cord Institute partnered to further scale the device for mass commercialisation.

Abilitech Medical has secured a Medical Device Establishment License (MDEL) from Health Canada for the sale of its orthotic device to patients in the country.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Launched in the US last year, the company’s wearable assistive device, Abilitech Assist, is claimed to be the first and only powered orthotic device to include shoulder assistance.

It uses a combination of custom-calibrated springs, motors and firmware to provide functional independence to patients who cannot move their arms.

When wearing the external device, users will be able to lift objects weighing up to 12oz. It also supports a range of motion at the elbow and shoulder.

Abilitech and the Praxis Spinal Cord Institute collaborated last year to further scale Abilitech Assist for mass commercialisation.

Abilitech Medical founder and CEO Angie Conley said: “We’re proud to have entered the Canadian marketplace, effectively immediately.

“There are many individuals with spinal cord injuries, muscular dystrophy, multiple sclerosis and other neuromuscular disorders who will benefit from our assistive technology and are anxious to perform daily activities like eating, brushing teeth and opening doors.”

“Our device is intuitive and easy to use, can be leveraged in numerous settings and benefits families, as well as patients by lessening the burden of care.”

The hybrid system includes clinician and user-friendly adjustments, along with a slim and breathable body jacket that supports the weight of the device.

Furthermore, the lightweight, comfortable device enables patients with upper-limb weakness to use their own strength for arm movements.

With this commercial licence in place, Abilitech can now work with medical device partners within Canada.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network